Neurology Edition: Top Headlines for Week of June 13, 2022

In this week’s edition, CAR-T ‘robustly effective’ in younger patients with deadly form of brain cancer; SARS-CoV-2 linked to range of neurological diseases; Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability; and more.

Read the full coverage here:

Steerable microcatheter nets FDA 510(k) clearance for neurologic, peripheral, coronary use

CAR-T ‘robustly effective’ in younger patients with deadly form of brain cancer

SARS-CoV-2 linked to range of neurological diseases

Risk for major adverse CV events elevated with type 2 diabetes, cognitive impairment

Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability

References:

Press Release

Majzner RG, et al. Abstract CT001. Presented at: American Association for Cancer Research Annual Meeting; April 8-13, 2022; New Orleans.

Klein RS, et al. Neurobiology of COVID-19. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.

Cukierman-Yaffe T, et al. J Clin Endocrinol Metab. 2022;doi:10.1210/clinem/dgac200

Dybjer E, et al. Diabet Med. 2022;doi:10.1111/dme.14806.